Platelet-Rich Fibrin in Third Molar Surgery: Systematic Review and Meta-Analysis Protocol.

IF 0.8 Q4 DENTISTRY, ORAL SURGERY & MEDICINE Craniomaxillofacial Trauma & Reconstruction Pub Date : 2022-06-01 Epub Date: 2021-05-06 DOI:10.1177/19433875211016203
Gaston A Salas, Shuheng A Lai, Francisca Verdugo-Paiva, Roberto A Requena
{"title":"Platelet-Rich Fibrin in Third Molar Surgery: Systematic Review and Meta-Analysis Protocol.","authors":"Gaston A Salas, Shuheng A Lai, Francisca Verdugo-Paiva, Roberto A Requena","doi":"10.1177/19433875211016203","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this systematic review is to assess the effectiveness and safety of platelet-rich fibrin (PRF) in third molar surgery.</p><p><strong>Data sources: </strong>A comprehensive search strategy is meant to be used in an attempt to identify all relevant randomized controlled trials (RCTs), ongoing investigation reported in specialty congresses and trials regardless of language or publication status (published, unpublished, in press and in progress). Searches will be conducted in the Cochrane Central Register of Controlled Trials (CENTRAL), PUBMED, Embase, Lilacs, the International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, US National Institutes of Health (NIH), grey literature and in specialized congresses and conferences.</p><p><strong>Eligibility criteria: </strong>We will include randomized trials evaluating the effect of PRF on wound healing after third molar surgery. Two reviewers will independently screen each study for eligibility, data extraction and risk of bias assessment using Cochrane \"risk of bias\" tool. We will pool the results using meta-analysis and will apply the GRADE system to assess the certainty of the evidence for each outcome.</p><p><strong>Ethics and dissemination: </strong>As researchers will not access information that could lead to the identification of an individual participant, obtaining ethical approval was waived.</p>","PeriodicalId":46447,"journal":{"name":"Craniomaxillofacial Trauma & Reconstruction","volume":"15 2","pages":"164-168"},"PeriodicalIF":0.8000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133523/pdf/10.1177_19433875211016203.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Craniomaxillofacial Trauma & Reconstruction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19433875211016203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/5/6 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The objective of this systematic review is to assess the effectiveness and safety of platelet-rich fibrin (PRF) in third molar surgery.

Data sources: A comprehensive search strategy is meant to be used in an attempt to identify all relevant randomized controlled trials (RCTs), ongoing investigation reported in specialty congresses and trials regardless of language or publication status (published, unpublished, in press and in progress). Searches will be conducted in the Cochrane Central Register of Controlled Trials (CENTRAL), PUBMED, Embase, Lilacs, the International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, US National Institutes of Health (NIH), grey literature and in specialized congresses and conferences.

Eligibility criteria: We will include randomized trials evaluating the effect of PRF on wound healing after third molar surgery. Two reviewers will independently screen each study for eligibility, data extraction and risk of bias assessment using Cochrane "risk of bias" tool. We will pool the results using meta-analysis and will apply the GRADE system to assess the certainty of the evidence for each outcome.

Ethics and dissemination: As researchers will not access information that could lead to the identification of an individual participant, obtaining ethical approval was waived.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
富血小板纤维蛋白在第三磨牙手术中的应用:系统综述和元分析协议》。
目的:本系统综述旨在评估富血小板纤维蛋白(PRF)在第三磨牙手术中的有效性和安全性:将采用全面的检索策略,试图找出所有相关的随机对照试验 (RCT)、在专业大会上报告的正在进行的调查和试验,而不论其语言或出版状态(已出版、未出版、出版中和进行中)。我们将在科克伦对照试验中央登记册(CENTRAL)、PUBMED、Embase、Lilacs、国际临床试验登记平台(ICTRP)、ClinicalTrials.gov、美国国立卫生研究院(NIH)、灰色文献以及专业大会和会议上进行检索:我们将纳入评估 PRF 对第三磨牙手术后伤口愈合效果的随机试验。两名审稿人将使用 Cochrane "偏倚风险 "工具对每项研究的资格、数据提取和偏倚风险评估进行独立筛选。我们将采用荟萃分析法对结果进行汇总,并采用 GRADE 系统对每项结果的证据确定性进行评估:由于研究人员不会获取可能导致识别个别参与者的信息,因此无需获得伦理批准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Craniomaxillofacial Trauma & Reconstruction
Craniomaxillofacial Trauma & Reconstruction DENTISTRY, ORAL SURGERY & MEDICINE-
自引率
0.00%
发文量
39
期刊最新文献
Guidelines for Orbital Defect Assessment and Patient-Specific Implant Design: Introducing OA2 (Orbital Assessment Algorithm). Moving Forward: The Last Subscription Issue and the Dawn of Open Access. Opportunity Cost of Surgical Management of Craniomaxillofacial Trauma: A Longitudinal Study. Does More Invasive Surgery Result in Higher Patient Satisfaction? A Long-Term Follow-Up of 136 Zygomaticomaxillary Complex Fractures. Microvascular Reconstructions in Elderly Patients With Oral Squamous Cell Carcinoma - Too Old for Surgical Treatment?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1